PuSH - Publication Server of Helmholtz Zentrum München

Andor, N. ; Graham, T.A.* ; Jansen, M.A.* ; Xia, L.C.* ; Aktipis, C.A.* ; Petritsch, C.* ; Ji, H.P.* ; Maley, C.C.*

Pan-cancer analysis of the extent and consequences of intratumor heterogeneity.

J. Nat. Med. 22, 105-113 (2016)
DOI
Open Access Green as soon as Postprint is submitted to ZB.
Intratumor heterogeneity (ITH) drives neoplastic progression and therapeutic resistance. We used the bioinformatics tools 'expanding ploidy and allele frequency on nested subpopulations' (EXPANDS) and PyClone to detect clones that are present at a â ‰1 10% frequency in 1,165 exome sequences from tumors in The Cancer Genome Atlas. 86% of tumors across 12 cancer types had at least two clones. ITH in the morphology of nuclei was associated with genetic ITH (Spearman's correlation coefficient, ρ = 0.24-0.41; P < 0.001). Mutation of a driver gene that typically appears in smaller clones was a survival risk factor (hazard ratio (HR) = 2.15, 95% confidence interval (CI): 1.71-2.69). The risk of mortality also increased when >2 clones coexisted in the same tumor sample (HR = 1.49, 95% CI: 1.20-1.87). In two independent data sets, copy-number alterations affecting either <25% or >75% of a tumor's genome predicted reduced risk (HR = 0.15, 95% CI: 0.08-0.29). Mortality risk also declined when >4 clones coexisted in the sample, suggesting a trade-off between the costs and benefits of genomic instability. ITH and genomic instability thus have the potential to be useful measures that can universally be applied to all cancers.
Altmetric
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Corresponding Author
ISSN (print) / ISBN 1340-3443
e-ISSN 1861-0293
Quellenangaben Volume: 22, Issue: 1, Pages: 105-113 Article Number: , Supplement: ,
Publisher Springer
Publishing Place Tokyo [u.a.]
Non-patent literature Publications
Reviewing status Peer reviewed